Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
Global Key SolutionsGKS
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Brio Pharmaceuticals Inc
FDA Inspection
•Brio Pharmaceuticals Inc•February 27, 2026

FDA Inspection 1304746 - Brio Pharmaceuticals Inc - February 27, 2026

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Brio Pharmaceuticals Inc, with an inspection on February 27, 2026, issued by the Dallas District Office, covering human drugs.

Company
Brio Pharmaceuticals Inc
Inspection Date
February 27, 2026
Product Type
Human Drugs
Office
Dallas District Office
Open in Dashboard

ID · 215855d7-cef6-4306-9ed7-1cf6d2c8aaba

Violation Codes2
21 CFR 211.166(a)21 CFR 211.22(d)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.